Zobrazeno 1 - 6
of 6
pro vyhledávání: '"very low disease activity"'
Autor:
Stephanie G. Werner, Xenofon Baraliakos, Sabine Reckert, Martin Bohl-Bühler, Marie-Claude Laliberté, Tanya Girard, Katharina Jeromin, Nikola Baschuk, Björn Fritz, Louis Bessette, Axel J. Hueber
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1503-1518 (2023)
Abstract Introduction Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observational, prospective, m
Externí odkaz:
https://doaj.org/article/a787fb929fe14fb9989f5c14f59ca8bb
Autor:
Ennio Lubrano, Fabio Massimo Perrotta, Silvia Scriffignano, Laura C. Coates, Philip Helliwell
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 4, Pp 521-528 (2019)
Abstract Introduction Sustained remission should be considered the main therapeutic target in psoriatic arthritis (PsA). Very low disease activity (VLDA) and a DAPSA score ≤ 4 are the most commonly used criteria. The aim of the present study was to
Externí odkaz:
https://doaj.org/article/4b7d0d8d69e44901bdce5d645213d557
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mustafa Çaliş, Murat Toprak, Halise Hande Gezer, Hatice Bodur, Cevriye Mülkoğlu, Fikriye Figen Ayhan, Nihan Cuzdan, Oznur Kutluk, Ajda Bal, Nilay Sahin, Gizem Cengiz, Tiraje Tuncer, İbrahim Tekeoğlu, Sena Tolu, Ilknur Albayrak Gezer, Betul Sargin, Meltem Alkan Melikoglu, Sami Hizmetli, Nesrin Şen, Sevtap Acer Kasman, Hakan Alkan, Dilek Keskin, Kevser Gok, Yaşar Keskin, Gul Devrimsel, Erhan Capkin, Ayhan Kamanli, Erkan Kilic, Okan Küçükakkaş, Hilal Ecesoy, Mehmet Tuncay Duruöz, Ömer Faruk Şendur, Ozan Volkan Yurdakul, Hatice Reşorlu, İsmihan Sunar, Merve Baykul, Kemal Nas
Objective: Currently, concerning the evaluation of psoriatic arthritis (PsA), there is no agreement on a standardized composite index for disease activity that includes all relevant domains. The present study sought to assess the rates of remission (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b534ea3a095638435f61d6253b249452
https://avesis.yyu.edu.tr/publication/details/e073dc1e-d7d7-4762-be05-147250089b2f/oai
https://avesis.yyu.edu.tr/publication/details/e073dc1e-d7d7-4762-be05-147250089b2f/oai
Autor:
Philip S. Helliwell, Fabio Massimo Perrotta, Ennio Lubrano, Laura C. Coates, Silvia Scriffignano
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, Vol 6, Iss 4, Pp 521-528 (2019)
Rheumatology and Therapy, Vol 6, Iss 4, Pp 521-528 (2019)
Introduction: Sustained remission should be considered the main therapeutic target in psoriatic arthritis (PsA). Very low disease activity (VLDA) and a DAPSA score ≤ 4 are the most commonly used criteria. The aim of the present study was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9528980ceae2614c5dd24543d6f0feb5
https://hdl.handle.net/11695/88947
https://hdl.handle.net/11695/88947
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.